Showing results (931-940 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|March 3, 2022
Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controlsAndreas Andersen, Peter G Jørgensen, Jonatan I Bagger, et al.
Diabetes, Obesity & Metabolism|July 3, 2019
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized studyRichard E Pratley, Jahoon Kang, Michael E Trautmann, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DMDavid R Matthews, Päivi M Paldánius, Michael Stumvoll, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Use of fast-acting insulin aspart in insulin pump therapy in clinical practiceMark Evans, Antonio Ceriello, Thomas Danne, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotideCaroline Christfort Øhrstrøm, Dorte Worm, Anna Højager, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the sodium-glucose co-transporter-2 inhibitor tofogliflozin, in relation to weight lossYuichi Sato, Kiyohide Nunoi, Kohei Kaku, et al.
Diabetes, Obesity & Metabolism|January 23, 2010
Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER studyA Fritsche, M Larbig, D Owens, et al.
Diabetes, Obesity & Metabolism|August 24, 2018
Real-world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research-to-practice" project from the diabetes collaborative registrySuzanne V Arnold, Leo Seman, Fengming Tang, et al.
Diabetes, Obesity & Metabolism|August 28, 2018
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptinSumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.
Pageof 632